Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 182 |
|
|||||
| News | - | ||||||
| Day High | 182.995 | Low High |
|||||
| Day Low | 180.05 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Csl Ltd (QX) | CMXHF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 3.85 | 2.19% | 180.05 | 16:01:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 182.995 | 180.05 | 182.995 | 180.05 | 176.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2 | 182 | $ 182.1859 | $ 33,158 | - | 144.81 - 207.674 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:53:48 | 50 | $ 180.05 | USD |
Csl Ltd (QX) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 133.44B | 482.37M | - | 13.17B | 2.19B | 4.54 | 60.82 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Csl (QX) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CMXHF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 183.00 | 183.00 | 175.80 | 176.57 | 111 | -2.95 | -1.61% |
| 1 Month | 184.265 | 188.25 | 172.4838 | 176.25 | 167 | -4.21 | -2.29% |
| 3 Months | 193.90 | 196.95 | 172.4838 | 183.13 | 225 | -13.85 | -7.14% |
| 6 Months | 156.76 | 201.25 | 155.0001 | 183.24 | 401 | 23.29 | 14.86% |
| 1 Year | 196.251 | 207.674 | 144.81 | 173.92 | 572 | -16.20 | -8.26% |
| 3 Years | 209.295 | 239.41 | 144.81 | 190.96 | 592 | -29.25 | -13.97% |
| 5 Years | 138.92 | 239.41 | 137.00 | 189.67 | 527 | 41.13 | 29.61% |
Csl (QX) Description
| CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. |
